MAPK3 and fibrosis: Activated ERK1/2, a known regulator of cardiac fibrosis that has been observed in various models of mitral valve disease [43,44] is also increased in Pdgfra depleted valves in similar regions and in valve endothelial cells treated with PDGFR inhibitor.